BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20629582)

  • 1. Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.
    Sangar MC; Bansal S; Avadhani NG
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1231-51. PubMed ID: 20629582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.
    Bhattacharyya S; Sinha K; Sil PC
    Curr Drug Metab; 2014; 15(7):719-42. PubMed ID: 25429675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals.
    Avadhani NG; Sangar MC; Bansal S; Bajpai P
    FEBS J; 2011 Nov; 278(22):4218-29. PubMed ID: 21929726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms regulating the mitochondrial targeting of microsomal cytochrome P450 enzymes.
    Ahn T; Yun CH
    Curr Drug Metab; 2010 Dec; 11(10):830-8. PubMed ID: 21208176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
    Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.
    Gao J; Zhou J; He XP; Zhang YF; Gao N; Tian X; Fang Y; Wen Q; Jia LJ; Jin H; Qiao HL
    Oncotarget; 2016 May; 7(19):28612-23. PubMed ID: 27086920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive and inducible cytochromes P450 in rat lung mitochondria: xenobiotic induction, relative abundance, and catalytic properties.
    Bhagwat SV; Mullick J; Raza H; Avadhani NG
    Toxicol Appl Pharmacol; 1999 May; 156(3):231-40. PubMed ID: 10222315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research.
    Masimirembwa CM; Otter C; Berg M; Jönsson M; Leidvik B; Jonsson E; Johansson T; Bäckman A; Edlund A; Andersson TB
    Drug Metab Dispos; 1999 Oct; 27(10):1117-22. PubMed ID: 10497136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED; Thummel KE
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular transport and localization of microsomal cytochrome P450.
    Neve EP; Ingelman-Sundberg M
    Anal Bioanal Chem; 2008 Nov; 392(6):1075-84. PubMed ID: 18537026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary origin of mitochondrial cytochrome P450.
    Omura T; Gotoh O
    J Biochem; 2017 May; 161(5):399-407. PubMed ID: 28338801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial targeting of intact CYP2B1 and CYP2E1 and N-terminal truncated CYP1A1 proteins in Saccharomyces cerevisiae--role of protein kinase A in the mitochondrial targeting of CYP2E1.
    Sepuri NB; Yadav S; Anandatheerthavarada HK; Avadhani NG
    FEBS J; 2007 Sep; 274(17):4615-30. PubMed ID: 17697118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.
    Neve EP; Ingelman-Sundberg M
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):78-85. PubMed ID: 20047148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial P450s.
    Omura T
    Chem Biol Interact; 2006 Oct; 163(1-2):86-93. PubMed ID: 16884708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.
    McGinnity DF; Parker AJ; Soars M; Riley RJ
    Drug Metab Dispos; 2000 Nov; 28(11):1327-34. PubMed ID: 11038161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
    Lewis DF; Ito Y
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility.
    Bhagwat SV; Boyd MR; Ravindranath V
    Arch Biochem Biophys; 1995 Jun; 320(1):73-83. PubMed ID: 7793987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
    Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of theophylline by cDNA-expressed human cytochromes P-450.
    Ha HR; Chen J; Freiburghaus AU; Follath F
    Br J Clin Pharmacol; 1995 Mar; 39(3):321-6. PubMed ID: 7619675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: differing responses to dietary benzo[a]pyrene as proof of principle.
    Dong H; Dalton TP; Miller ML; Chen Y; Uno S; Shi Z; Shertzer HG; Bansal S; Avadhani NG; Nebert DW
    Mol Pharmacol; 2009 Mar; 75(3):555-67. PubMed ID: 19047483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.